Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Marchetti

Showing results (1-10 of 128) with videos related to

Pageof 13
Sort By:
Recenti Progressi in Medicina|June 15, 2021
[Pathological pathway adaptations for adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA).]Antonio Marchetti, Emanuela D'Angelo
Oncotarget|March 9, 2022
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptationsAntonio Marchetti, Fiamma Buttitta, Emanuela D'Angelo
Oncotarget|December 21, 2019
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatmentsAntonio Marchetti, Alessia Di Lorito, Lara Felicioni, et al.
Studies in Health Technology and Informatics|October 3, 2025
Benchmarking Large Language Models for Italian Medical Text Classification: Are Generative Models the Best Choice?Livia Lilli, Stefano Patarnello, Carlotta Masciocchi, et al.
Biomed Research International|February 25, 2014
Determinants of noninvasive ventilation outcomes during an episode of acute hypercapnic respiratory failure in chronic obstructive pulmonary disease: the effects of comorbidities and causes of respiratory failureAngela Maria Grazia Pacilli, Ilaria Valentini, Paolo Carbonara, et al.
Journal of Translational Medicine|January 23, 2017
Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?Giuseppe Palmieri, Maria Colombino, Antonio Cossu, et al.
Pathologica|July 1, 2022
NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategiesAntonio Marchetti, Benedetta Ferro, Maria Paola Pasciuto, et al.
Future Oncology (London, England)|July 13, 2021
Molecular tests and target therapies in oncology: recommendations from the Italian workshopCarmine Pinto, Mauro Biffoni, Patrizia Popoli, et al.
Clinical Lung Cancer|June 26, 2018
Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget EffectDavide Paolini, Marcello Tiseo, Federica Demma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivationGiulia Bon, Valentina Folgiero, Gianluca Bossi, et al.
Pageof 13

Showing results (1-10 of 128) with videos related to

Sort By:
Pageof 13
Recenti Progressi in Medicina|June 15, 2021
[Pathological pathway adaptations for adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA).]Antonio Marchetti, Emanuela D'Angelo
Oncotarget|March 9, 2022
Adjuvant osimertinib treatment in patients with early stage NSCLC (IB-IIIA): pathological pathway adaptationsAntonio Marchetti, Fiamma Buttitta, Emanuela D'Angelo
Oncotarget|December 21, 2019
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatmentsAntonio Marchetti, Alessia Di Lorito, Lara Felicioni, et al.
Studies in Health Technology and Informatics|October 3, 2025
Benchmarking Large Language Models for Italian Medical Text Classification: Are Generative Models the Best Choice?Livia Lilli, Stefano Patarnello, Carlotta Masciocchi, et al.
Biomed Research International|February 25, 2014
Determinants of noninvasive ventilation outcomes during an episode of acute hypercapnic respiratory failure in chronic obstructive pulmonary disease: the effects of comorbidities and causes of respiratory failureAngela Maria Grazia Pacilli, Ilaria Valentini, Paolo Carbonara, et al.
Journal of Translational Medicine|January 23, 2017
Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immunotherapy?Giuseppe Palmieri, Maria Colombino, Antonio Cossu, et al.
Pathologica|July 1, 2022
NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategiesAntonio Marchetti, Benedetta Ferro, Maria Paola Pasciuto, et al.
Future Oncology (London, England)|July 13, 2021
Molecular tests and target therapies in oncology: recommendations from the Italian workshopCarmine Pinto, Mauro Biffoni, Patrizia Popoli, et al.
Clinical Lung Cancer|June 26, 2018
Ventana ALK (D5F3) in the Detection of Patients Affected by Anaplastic Lymphoma Kinase-positive Non-Small-cell Lung Cancer: Clinical and Budget EffectDavide Paolini, Marcello Tiseo, Federica Demma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2006
Loss of beta4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivationGiulia Bon, Valentina Folgiero, Gianluca Bossi, et al.
Pageof 13